Caveolin-1 contributes to realgar nanoparticle therapy in human chronic myelogenous leukemia K562 cells
Dan Shi,1,* Yan Liu,1,* Ronggang Xi,1 Wei Zou,2 Lijun Wu,3 Zhiran Zhang,1 Zhongyang Liu,1 Chao Qu,1 Baoli Xu,1 Xiaobo Wang1 1Department of Pharmacy, The 210th Hospital of People’s Liberation Army, 2College of Life Science, Liaoning Normal University, Dalian, Liaoning, 3Department of Pharm...
Saved in:
Main Authors: | Shi D, Liu Y, Xi RG, Zou W, Wu LJ, Zhang ZR, Liu ZY, Qu C, Xu BL, Wang XB |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/04bc20cf71504c42a1d6be335d707253 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frecuencia de los genes de fusión TEL/AML1 y BCR/ABL en pacientes pediátricos con leucemia linfoblástica aguda
by: Artigas A,Carmen Gloria, et al.
Published: (2006) -
Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
by: Amin Huma, et al.
Published: (2021) -
JKST6, a novel multikinase modulator of the BCR-ABL1/STAT5 signaling pathway that potentiates direct BCR-ABL1 inhibition and overcomes imatinib resistance in chronic myelogenous leukemia
by: Haidée Aranda-Tavío, et al.
Published: (2021) -
Properties of realgar bioleaching using an extremely acidophilic bacterium and its antitumor mechanism as an anticancer agent
by: Chen,Peng, et al.
Published: (2017) -
TRANSCRIPTOS DE FUSIÓN DEL GEN BCR/ABL EN PACIENTES CON LEUCEMIA MIELOIDE CRÓNICA
by: Artigas,Carmen Gloria, et al.
Published: (2003)